Radiation Dose Management Market Worth $447 million in 2024 – Modality (Computed Tomography, Nuclear Medicine)


Posted June 16, 2020 by healthcaremarket

The radiation dose management market is projected to reach USD 447 million by 2024 from USD 206 million in 2019, at a CAGR of 16.7% during the forecast period
 
Growth in the market is mainly driven by the increasing use of medical imaging modalities due to the rising incidence of chronic diseases, increasing concerns over radiation dose exposure, growth in the installed base of radiology equipment, and growing awareness on radiation dose management.

The radiation dose management market is projected to reach USD 447 million by 2024 from USD 206 million in 2019, at a CAGR of 16.7% during the forecast period.
What Drives the Market?

1. Increasing Usage of Medical Imaging Modalities Due to Rising Incidences of Chronic Diseases
2. Increasing Concerns Over Radiation Dose Exposure
3. Growth in the Installed Base of Radiology Equipment
4. Growing Awareness on Radiation Dose Management

By modality, the market is segmented into computed tomography (CT), fluoroscopy and interventional imaging, mammography, and nuclear medicine. The computed tomography segment accounted for the largest market share in 2018. The large share of this segment can be attributed to the increasing number of CT examinations worldwide and the rising awareness of radiation dose exposure.

Get a sample PDF copy of the Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82326344

The radiation dose management solutions segment is expected to grow at the highest CAGR during the forecast period
Based on product & service, the market is segmented into radiation dose management solutions and radiation dose management services. The radiation dose management solutions segment is projected to witness the highest growth during the forecast period.

The geographical regions mapped in the report are:
1. North America
2. Europe
3. Asia-Pacific
4. Rest of the World (RoW)

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2018, North America accounted for the largest share of the market. The large share of North America can be attributed to factors such as the stringent legislative and accreditation requirements regarding the reporting and optimization of radiation doses, high adoption of HCIT technologies, and the presence of stringent regulatory requirements regarding patient safety.

Some key players mentioned in the research report are:

Key players in the global radiation dose management industry are Bayer AG (Germany), GE Healthcare (US), PACSHealth, LLC (US), and Sectra Medical Systems (Sweden). Other prominent players in this market include Philips Healthcare (Netherlands), Fujifilm Holdings Corporation (Japan), Novarad Corporation (US), Siemens Healthineers (Germany), Agfa HealthCare (Belgium), Canon (Japan), and Qaelum N.V. (Belgium).

To get a 10% Customization on the report, click @https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=82326344
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By marketsandmarkets
Country United States
Categories Government , Health , News
Tags radiation dose management market
Last Updated June 16, 2020